Clinical Trial Update: A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome. [EARLY_Phase 1]

View source ↗

Summary

A clinical trial update for IMC-001 in patients with atherosclerosis aiming to improve plaque stability in acute coronary syndrome (early Phase 1, recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Syndrome

Drugs mentioned

• IMC-001

Snippet

Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | Conditions: Atherosclerosis | EARLY_Phase 1 | Status: RECRUITING